Literature DB >> 27017149

The Acute Risks of Exercise in Apparently Healthy Adults and Relevance for Prevention of Cardiovascular Events.

Jack M Goodman1, Jamie F Burr2, Laura Banks3, Scott G Thomas3.   

Abstract

BACKGROUND: Increased physical activity (PA) is associated with improved quality of life and reductions in cardiovascular (CV) morbidity and all-cause mortality in the general population in a dose-response manner. However, PA acutely increases the risk of adverse CV event or sudden cardiac death (SCD) above levels expected at rest. We review the likelihood of adverse CV events related to exercise in apparently healthy adults and strategies for prevention, and contextualize our understanding of the long-term risk reduction conferred from PA.
METHODS: A systematic review of the literature was performed using electronic databases; additional hand-picked relevant articles from reference lists and additional sources were included after the search.
RESULTS: The incidence of adverse CV events in adults is extremely low during and immediately after PA of varying types and intensities and is significantly lower in those with long-standing PA experience. The risk of SCD and nonfatal events during and immediately after PA remains extremely low (well below 0.01 per 10,000 participant hours); increasing age and PA intensity are associated with greater risk. In most cases of exercise-related SCD, occult CV disease is present and SCD is typically the first clinical event.
CONCLUSIONS: Exercise acutely increases the risk of adverse CV events, with greater risk associated with vigorous intensity. The risks of an adverse CV event during and immediately after exercise are outweighed by the health benefits of vigorous exercise performed regularly. A key challenge remains the identification of occult structural heart disease and inheritable conditions that increase the chances of lethal arrhythmias during exercise.
Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27017149     DOI: 10.1016/j.cjca.2016.01.019

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  12 in total

Review 1.  The prevention and management of sudden cardiac arrest in athletes.

Authors:  Yehia Fanous; Paul Dorian
Journal:  CMAJ       Date:  2019-07-15       Impact factor: 8.262

2.  Effects of exercise intensity and cardiorespiratory fitness on the acute response of arterial stiffness to exercise in older adults.

Authors:  Maria Perissiou; Tom G Bailey; Mark Windsor; Michael Chi Yuan Nam; Kim Greaves; Anthony S Leicht; Jonathan Golledge; Christopher D Askew
Journal:  Eur J Appl Physiol       Date:  2018-05-30       Impact factor: 3.078

3.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

Review 4.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

5.  Deficiency in nebulin repeats of sarcomeric nebulette is detrimental for cardiomyocyte tolerance to exercise and biomechanical stress.

Authors:  Ramona M Vejandla; Buyan-Ochir Orgil; Neely R Alberson; Ning Li; Undral Munkhsaikhan; Zaza Khuchua; Ruben Martherus; Evren U Azeloglu; Fuyi Xu; Lu Lu; Jeffrey A Towbin; Enkhsaikhan Purevjav
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-16       Impact factor: 4.733

6.  Impact of acute dynamic exercise and arterial shear rate modification on radial artery low-flow mediated constriction in young men.

Authors:  Mohammad H Alali; Rebekah A I Lucas; Rehan T Junejo; James P Fisher
Journal:  Eur J Appl Physiol       Date:  2022-05-13       Impact factor: 3.346

7.  Impact of commonly prescribed exercise interventions on platelet activation in physically inactive and overweight men.

Authors:  Andrew Haynes; Matthew D Linden; Elisa Robey; Gerald F Watts; Hugh Barrett; Louise H Naylor; Daniel J Green
Journal:  Physiol Rep       Date:  2016-10-17

8.  An expanded repertoire of intensity-dependent exercise-responsive plasma proteins tied to loci of human disease risk.

Authors:  J Sawalla Guseh; Timothy W Churchill; Anthony Rosenzweig; Aaron L Baggish; Ashish Yeri; Claire Lo; Marcel Brown; Nicholas E Houstis; Krishna G Aragam; Daniel E Lieberman
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

9.  Assessment of cardiovascular risk and preparticipation screening protocols in masters athletes: the Masters Athlete Screening Study (MASS): a cross-sectional study.

Authors:  Barbara N Morrison; James McKinney; Saul Isserow; Daniel Lithwick; Jack Taunton; Hamed Nazzari; Astrid M De Souza; Brett Heilbron; Carlee Cater; Mackenzie MacDonald; Benjamin A Hives; Darren E R Warburton
Journal:  BMJ Open Sport Exerc Med       Date:  2018-08-09

10.  Are changes in physical fitness, body composition and weight associated with exercise attendance and dropout among fitness club members? Longitudinal prospective study.

Authors:  Christina Gjestvang; Trine Stensrud; Lene A H Haakstad
Journal:  BMJ Open       Date:  2019-04-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.